Not applicableStudy completedNCT01508273What this trial is testingLifestyle Intervention for High Risk Cancer SurvivorsWho this might be right forBreast Cancer M.D. Anderson Cancer Center 1,150
Early research (Phase 1)Study completedNCT01133912What this trial is testingPreoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)Who this might be right forBreast Cancer Jungsil Ro 13
Early research (Phase 1)Study completedNCT00050167What this trial is testingEvaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast CancerWho this might be right forBreast Cancer M.D. Anderson Cancer Center 603
Not applicableUnknownNCT03647280What this trial is testingThe Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerWho this might be right forBreast Cancer Zhejiang Cancer Hospital 50
Large-scale testing (Phase 3)Study completedNCT00129389What this trial is testingFAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer PatientsWho this might be right forBreast Cancer Spanish Breast Cancer Research Group 1,925
Large-scale testing (Phase 3)WithdrawnNCT05474690What this trial is testingA Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast CancerWho this might be right forBreast CancerHER2-positive Breast Cancer Henan Cancer Hospital
Not applicableStudy completedNCT02744079What this trial is testingComparison of Healthy Diets on Breast Cancer MarkersWho this might be right forBreast Neoplasms Albert Einstein College of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT00633750What this trial is testingErlotinib in Treating Patients With Breast Cancer That Can Be Removed by SurgeryWho this might be right forBreast Cancer Vanderbilt-Ingram Cancer Center 50
Large-scale testing (Phase 3)UnknownNCT01222052What this trial is testing6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsWho this might be right forBreast Cancer Martin-Luther-Universität Halle-Wittenberg 4,150
Large-scale testing (Phase 3)Study completedNCT00130533What this trial is testingMaintenance Treatment With Capecitabine Versus Observation in Breast Cancer PatientsWho this might be right forBreast Cancer Spanish Breast Cancer Research Group 876
Testing effectiveness (Phase 2)Study completedNCT02339532What this trial is testingNeoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A StatusWho this might be right forBreast Cancer UNICANCER 86
Large-scale testing (Phase 3)Study completedNCT00129922What this trial is testingFluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerWho this might be right forBreast Cancer Spanish Breast Cancer Research Group 1,289
Testing effectiveness (Phase 2)UnknownNCT00518583What this trial is testingPhase II Study in Patients With Operable Breast CancerWho this might be right forBreast Cancer Aptium Oncology Research Network 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00616967What this trial is testingCarboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerWho this might be right forBreast Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 68
Large-scale testing (Phase 3)Study completedNCT01314833What this trial is testingMinus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer TherapyWho this might be right forPrimary Breast Cancer Fudan University 1,570
Not applicableUnknownNCT00488722What this trial is testingA Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast CancerWho this might be right forBreast Cancer Tianjin Medical University
Testing effectiveness (Phase 2)Study completedNCT00256360What this trial is testingTrial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast CancerWho this might be right forBreast Cancer Universitaire Ziekenhuizen KU Leuven 117
Large-scale testing (Phase 3)Study completedNCT02187744What this trial is testingPF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)Who this might be right forEarly Breast Cancer Pfizer 226
Testing effectiveness (Phase 2)Ended earlyNCT01319539What this trial is testingMK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+11 more National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT04127019What this trial is testingAdjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)Who this might be right forPrimary Breast Cancer Fudan University 2,079